Chronic autoimmune thyroiditis

New England Journal of Medicine

Volumn 335, Issue 2, 1996, Pages 99-107

  Dayan, Colin M ^a   Daniels, Gilbert H ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANTIBODY RESPONSE; DISEASE ASSOCIATION; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HYPOTHYROIDISM; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYROID FUNCTION TEST; THYROIDITIS;

HUMANS; PREVALENCE; THYROIDITIS, AUTOIMMUNE; THYROXINE;

EID: 0029896946     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607113350206     Document Type: Review

References (117)

1. Hashimoto H. Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir 1912;97:219-48.
2. Roitt IM, Doniach D, Campbell PN, Hudson RV. Auto-antibodies in Hashimoto's disease (lymphadenoid goitre). Lancet 1956;2:820-1.
3. Nagataki S. The concept of Hashimoto disease. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:539-45.
4. Costa A, Torchio B, Zoppetti G, Feyless E. What is meant today by Hashimoto's thyroiditis? J Endocrinol Invest 1989;12:355-6.
5. Volpé R. Autoimmune thyroiditis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. 6th ed. Philadelphia: J.B. Lippincott, 1991:921-33.
6. Hay ID. Thyroiditis: a clinical update. Mayo Clin Proc 1985;60:836-43.
7. Livolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid 1994;4:333-9.
8. Vickery AL, Hambtin E Jr. Struma lymphomatosa (Hashimoto's thyroiditis): observations on repeated biopsies in sixteen patients. N Engl J Med 1961;264:226-9.
9. Hayashi Y, Tamai H, Fukata S, et al. A long term clinical, immunological, and histological follow-up study of patients with goitrous chronic lymphocytic thyroiditis. J Clin Endocrinol Metab 1985;61:1172-8.
10. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994;15:788-830.
11. Dayan CM, Londei M, Corcoran AE, et al. Autoantigen recognition by thyroid-infiltrating T cells in Graves' disease. Proc Natl Acad Sci U S A 1991;88:7415-9.
12. Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 1991;325:238-44.
13. McIntosh RS, Tandon N, Pickerill AP, Davies R, Barnett D, Weetman AP IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease: analysis of V alpha transcript microheterogeneity. J Immunol 1993;151: 3884-93.
14. Valtonen VV, Ruutu P, Varis K, Ranki M, Malkamaki M, Makela PH. Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. Acta Med Scand 1986;219:105-11.
15. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993;14:107-20.
16. Drabick JJ, Horning VL, Lennox JL, et al. A retrospective analysis of diseases associated with indeterminate HIV Western blot patterns. Mil Med 1991;156:93-6.
17. Volpe R. A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder? Autoimmunity 1992;13:3-9.
18. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983;2:1111-5.
19. Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldman M. Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985;61:265-73.
20. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;2:1115-9.
21. Londei M, Bottazzo GF, Fcldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985;228:85-9.
22. Tandon N, Metcalfe RA, Barnett D, Weetman AP. Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. Q J Med 1994;87:231-6.
23. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid disease. FEBS Lett 1985;190:147-52.
24. Dumont JE, Roger PP, Ludgate M. Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts and misconceptions. Endocr Rev 1987;8:448-52.
25. Del Prete GF, Vercelli D, Tiri A, et al. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. Clin Exp Immunol 1986;65:140-7.
26. Kohno Y, Yamaguchi F, Saito K, Niimi H, Nishikawa T, Hosoya T. Anti-thyroid peroxidase antibodies in sera from healthy subjects and from patients with chronic thyroiditis: differences in the ability to inhibit thyroid peroxidase activities. Clin Exp Immunol 1991;85:459-63.
27. Khoury EL, Hammond L, Bottazzo GF, Doniach D. Presence of the organ specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol 1981;45:316-28.
28. Bogner U, Kotulla P, Peters H, Schleusener H. Thyroid peroxidase/ micmsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis. Acta Endocrinol 1990;123:431-7.
29. Chiovato L, Bassi P, Santini F, et al. Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 1993;77:1700-5.
30. Weetman AP, Cohen SB, Oleesky DA, Morgan BP. Terminal complement complexes and Cl/Cl inhibitor complexes in autoimmune thyroid disease. Clin Exp Immunol 1989;77:25-30.
31. Konishi J, Kasagi K, Iida Y. Thyroid stimulation blocking antibodies - an overview. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:573-7.
32. Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. J Clin Endocrinol Metab 1990;71:1382-6.
33. Takasu N, Yamada T, Takasu M, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992;326:513-8.
34. Phillips D, McLachlan S, Stephenson A, et al. Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol Metab 1990;70:742-6.
35. Phillips D, Prentice L, Upadhyaya M, et al. Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin - studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 1991;72:973-5.
36. Roitt IM, Doniach D. A reassessment of studies on the aggregation of thyroid autoimmunity in families of thyroiditis patients. Clin Exp Immunol 1967;2:Suppl:727-36.
37. Chopra IJ Solomon DH, Chopra U, Yoshihara E, Terasaki PI, Smith F. Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8. J Clin Endocrinol Metab 1977;45:45-54.
38. Honda K, Tamai J, Morita T, Kuma K, Nishimura Y, Sasazuki T Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 1989; 69:1268-73.
39. Tamai H, Kimura A, Dong R-P, et al. Resistance to autoimmune thyroid disease is associated with HLA-DQ. J Clin Endocrinol Metab 1994; 78:94-7.
40. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992;74:496-503.
41. Kennedy RL, Jones TH, Cuckle HS. Down's syndrome and the thyroid. Clin Endocrinol (Oxf) 1992;37:471-6.
42. Ewins DL, Rossor MN, Butler J, Roques PK, Mullan MJ, McGregor AM. Association between autoimmune thyroid disease and familial Alzheimer's disease. Clin Endocrinol (Oxf) 1991;35:93-6.
43. de Kerdanet M, Lucas J, Lemee F, Lecornu M. Turner's syndrome with X-isochromosome and Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1994;41:673-6.
44. Laurberg P. Iodine intake - what are we aiming at? J Clin Endocrinol Metab 1994;79:17-9.
45. Harach HR, Escalante DA, Onativia A, Outes JL, Day ES, Williams ED. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol (Copenh) 1985;108: 55-60.
46. Boukis MA, Koutras DA, Souvatzoglou A, Evangelopoulou A, Vrontakis M, Moulopoulos SD. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 1983;57:859-62.
47. Chow CC, Phillips DI, Lazarus JH, Parkes AB. Effect of low dose iodide supplementation on thyroid function in potentially susceptible subjects: are dietary iodide levels in Britain acceptable? Clin Endocrinol (Oxf) 1991;34:413-6.
48. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 1994;78:393-7.
49. Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab 1971;32:515-21.
50. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 1991;91:507-11.
51. Emerson CH, Dysno WL, Utiger RD. Serum thyrotropin and thyroxine concentrations in patients receiving lithium carbonate. J Clin Endocrinol Metab 1973;36:338-46.
52. Lazarus JH, John R, Bennie EH, Chalmers RJ, Crockctt G. Lithium therapy and thyroid function: a long-term study. Psychol Med 1981;11:85-92.
53. Burman P, Totterman TH, Oberg K, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 1986;63:1086-90.
54. Sauter NP, Atkins MB, Mier JW, Lechan RM. Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report. Am J Med 1992;92:441-4.
55. Gisslingcr H, Gilly B, Woloszczuk W, et al. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon alpha. Clin Exp Immunol 1992;90:363-7.
56. Imagawa A, Itoh N, Hanafusa T, et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 1995;80:922-6.
57. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988;318:1557-63.
58. Hoekman K, von Blomberg-van der Flier BME, Wagstaff J, Drexhage HA, Pinedo HM. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet 1991;338:541-2.
59. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N. The risk factors for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994;89:399-403.
60. Bhakri H, Sriskandan K, Davis T, Pettingale K, Tee D. Recombinant gamma interferon and autoimmune thyroid disease. Lancet 1985;2:457.
61. Williams ED, Doniach I. The post-mortem incidence of focal thyroiditis. J Pathol Bacteriol 1962;83:255-64.
62. Okayasu I, Hara Y, Nakamura K, Rose NR. Racial and age-related differences in incidence and severity of focal autoimmune thyroidicts. Am J Clin Pathol 1994;101:698-702.
63. Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1990;71:661-9.
64. Amino N, Hagen SR, Yamada N, Refetoff S. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 1976;5:115-25.
65. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977;7:481-93.
66. Barbato MP. Thyroid autoantibodies in an Australian community. Med J Aust 1978;2:511-2.
67. Mariotti S, Sansoni P, Barbesino G, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992;339:1506-8.
68. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991;34:77-83.
69. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years: a study in an urban US community. Arch Intern Med 1990; 150:7857.
70. Ladenson PW, Wilson WC, Gardin J, et al. Relationship of subclinical hypothyroidism to cardiovascular risk factors and disease in an elderly population. Thyroid 1994;4:Suppl 1:S-18. abstract.
71. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386-8.
72. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community, a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55-68.
73. Doniach D, Bottazzo GF, Russell RCG. Goitrous autoimmune thyroiditis (Hashimoto's disease). Clin Endocrinol Metab 1979;8:63-80.
74. Tsuboi K, Yuasa R, Tanaka Y, Ueshiba H, Takeda S, Ito K. Incidence of thyroid atrophy in patients with Hashimoto thyroiditis. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:69-72.
75. Rallison ML, Dobyns BM, Mcikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med 1991;91:363-70. [Erratum, Am J Med 1992;92:582.]
76. Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto's thyroiditis. Hum Pathol 1974;5:161-70.
77. Sostre S, Reyes MM. Sonographic diagnosis and grading of Hashimoto's thyroiditis. J Endocrinol Invest 1991;14:115-21.
78. Nordmeyer JP, Shafeh TA, Heckmann C. Thyroid sonography in autoimmune thyroiditis: a prospective study on 123 patients. Acta Endocrinol (Copenh) 1990;122:391-5.
79. Zimmerman RS, Brcnnan MD, McConahcy WM, Goellner JR, Gharib H. Hashimoto's thyroiditis: an uncommon cause of painful thyroid unresponsive to corticosteroid therapy. Ann Intern Med 1986;104: 3557.
80. Nordykc RA, Gilbert FI Jr, Miyamoto LA, Fleury KA. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Mcd 1993;153:862-5.
81. Ramtoola S, Maiscy MN, Clark SEM, Fogelman I. The thyroid scan in Hashimoto's thyroiditis: the great mimic. Nucl Med Commun 1988;9: 639-45.
82. Hypothyroidism and enlarging thyroid mass in a young woman. Am J Med 1993;95:534-41.
83. Ravinsky E, Safneck JR. Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol 1988;32:854-61.
84. Tani E, Skoog L. Fine needle aspiration cytology and immunocytochemistry in the diagnosis of lymphoid lesions of the thyroid gland. Acta Cytol 1989;33:48-52.
85. Tunbridge WMG, Brewis M, French JM, et al. Natural history of autoimmune thyroiditis. BMJ 1981;282:258-62.
86. Geul KW, van Sluisveld ILL, Grobbee DE, et al. The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin Endocrinol (Oxf) 1993;39:275-80.
87. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987; 258:209-13.
88. Lazarus JH, Burr ML, McGregor AM, et al. The prevalence and progression of autoimmune thyroid disease in the elderly. Acta Endocrinol (Copenh) 1984;106:199-202.
89. Gordin A, Lamberg B-A. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: a long-term follow-up study. Clin Endocrinol (Oxf) 1981;15:537-43.
90. Kurihara H, Sasaki J, Takamatsu M. Twenty cases with Hashimoto disease changing to Graves' disease. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:249-53.
91. Sugrue D, McEvoy M, Feely J, Drury MI. Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases. Q J Med 1980,49:51-61.
92. Wood LC, Ingbar SH. Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents. J Clin Invest 1979;64: 1429-36.
93. Hedley AJ, Young RE, Jones SJ, Alexander WD, Bewsher PD. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Clin Endocrinol (Oxf) 1989;31:209-18.
94. Kato I, Tajima K, Suchi T, et al. Chronic thyroiditis as a risk factor for B-cell lymphoma in the thyroid gland. Jpn J Cancer Res 1985:76:1085-90.
95. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993;3:93-9.
96. Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-4.
97. Aozasa K, Inoue A, Tajima K, Miyauchi A, Matsuzuka F, Kuma K. Malignant lymphomas of the thyroid gland: analysis of 79 patients with emphasis on histologic prognostic factors. Cancer 1986;58:100-4.
98. Maurer R, Taylor CR, Terry R, Lukes RJ. Non-Hodgkin lymphomas of the thyroid: a clinico-pathological review of 29 cases applying the Luke-Collins classification and an immunoperoxidase method. Virchows Arch A Pathol Anat Histol 1979;383:293-317.
99. Ocrtel JE, Heftess CS. Lymphoma of the thyroid and related disorders. Semin Oncol 1987;14:333-42.
100. Stagnaro-Grecn A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990;264:1422-5.
101. Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N. Antithyroid antibodies and the association with non-organ specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 1993;168:837-41.
102. Tamaki H, Amino N, Aozasa M, et al. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis. Am J Perinatol 1989;6:296-303.
103. Stagnaro-Green A. Postpartum thyroiditis: prevalence, etiology and clinical implications. Thyroid Today 1993;16:1-11.
104. Vargas MT, Briones Urbina R, Gladman D, Papsin FR, Walfish PG. Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab 1988;67:327-33.
105. Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC. The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol 1988;159:203-9.
106. Gerstein HC. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med 1990;150:1397-400.
107. Othman S, Phillips DIW, Parkes AB, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf) 1990;32:559-64.
108. Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab 1988;66:480-4.
109. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993;119:492-502.
110. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984;101:18-24.
111. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxinc treatment of women with "subclinical" hypothyroidism. Clin Endocrinol (Oxf) 1988;29:63-75.
112. Takasu N, Komiya I, Asawa T, Nagasawa Y, Yamada T. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto's thyroiditis. Lancet 1990;336:1084-6.
113. Utiger RD. Vanishing hypothyroidism. N Engl J Med 1992;326:562-3.
114. Hegedus L, Hansen JM, Feldt-Rasmussen U, Hansen BM, Hoier-Madsen M. Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1991;35:235-8.
115. Kikuchi T, Yamaguchi Y, Kobayashi T, et al. Studies on thyroid volume during thyroid hormone therapy in patients with Hashimoto thyroiditis. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993:201-3.
116. Chiovato L, Marcocci C, Mariotti S, Mori A, Pinchera A. L-thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto's thyroiditis. J Endocrinol Invest 1986;9:299-305.
117. Rieu M, Richard A, Rosilio M, et al. Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 1994;40:529-35.